A Clinical Study to Test How Effective and Safe GLPG1205 is for Participants With Idiopathic Pulmonary Fibrosis (IPF)
Clinical trial NCT03725852 · COMPLETED
Trial details
- NCT number
- NCT03725852
- Sponsor
- Lakefront Biotherapeutics NV
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-27
- Primary completion
- 2020-07-21
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.